ÂÜÀòÂÒÂ×

Vijay Iyengar joined Incyte in May 2016 as Executive Vice President, Global Strategy and Corporate Development leading the company’s Global Product Strategy, Business Development and Licensing, and Alliance Management teams. Dr. Iyengar has more than 13 years of pharmaceutical industry experience, most recently serving as the President of Genoptix Corporation, a Novartis Company. At Genoptix, he led a 650-person organization focused on delivering CAP/CLIA certified oncology diagnostic testing as well as providing clinical trial assay development and execution services. Previously, Dr. Iyengar held leadership roles in both U.S. and Global commercial functions at Novartis—he was Vice President and Rare Diseases Franchise Head at Novartis Oncology and Vice President and Oncology General Manager of Novartis Greece. Before joining Novartis in 2003, Dr. Iyengar was an Engagement Manager at McKinsey & Company where he served pharmaceutical and medical device clients as part of their healthcare practice. Dr. Iyengar received his Bachelor of Science degree in Biology from Stanford University and earned his MD from Harvard Medical School.